LSI USA '24

Monarch Beach Resort | Waldorf Astoria | March 18-22, 2024

LSI USA '24

Monarch Beach Resort | Waldorf Astoria | March 18-22, 2024

-Days
:
-Hours
:
-Minutes
:
-Seconds

LSI USA '24

Confirmed Presenting Companies

Presenting Companies (197)

Pavilion Showcase Companies (18)

Apply To Present
4D Biomaterials

4D Biomaterials is developing and commercializing resorbable photocurable resins for a wide range of implantable medical device applications. The company's 4Degra biomaterials are 3D printed and tailored based on the needs of the implants, from softer grades for meshes, and films to harder formulations for pins, screws, and load-bearing bone regeneration scaffolds. 4D Biomaterials currently offers three grades of its T-Series material, from the flexible T15 to the most supportive T2500.

Visit website.

Phil Smith
Phil Smith, CEO
4D Biomaterials

In-Person Presenter
A.I. Vali

A.I. Vali's AIDREA is a versatile AI platform that provides real-time medical image analysis from endoscopy video images and tissue biopsies. The AIDREA platform utilizes proprietary machine learning and deep learning techniques to empower physicians with accurate and reproducible insights that improve clinical care and aid in the early detection of cancer. 

Visit website.

Azar Azad
Azar Azad, CEO
A.I. Vali

In-Person Presenter
Access Vascular

Access Vascular is developing a suite of venous access devices that use our novel, patented biomaterial which is designed to prevent the most common and costly complications in venous access.

Visit website.

James Biggins
James Biggins, CEO
Access Vascular

In-Person Presenter
AccurKardia

AccurKardia is a digital-first and software-only healthcare company focused on enabling a world in which a combination of smart devices, reliable and actionable data, and efficient clinical intervention can together improve medical outcomes and save lives. AccurKardia provides clinical-grade, device-agnostic, API-accessible automated ECG analytics to clinical and consumer-grade ECG devices, as well as telehealth and remote patient monitoring companies

Visit website.

Juan C. Jimenez
Juan C. Jimenez, CEO
AccurKardia

In-Person Presenter
AiM Medical Robotics

AiM Medical Robotics is developing a portable MRI compatible surgical robot for use in the OP and MRI suite. The system is being designed for the treatment of functional brain disorders (e.g. epilepsy, Parkinson's disease).

Visit website.

Gregory Fischer
Gregory Fischer, Co-Founder & Chief Science Advisor
AiM Medical Robotics

In-Person Presenter
Allheartz

Allheartz is developing novel clinical AI-powered digital solutions to revolutionize home care in musculoskeletal (MSK) and sports health. The Software as a Medical Device (SaMD) platform innovated through the company's proprietary advanced computer vision applications turn an individual's smartphone into a medical-grade sensor. The platform is coupled with a remote HIPAA-compliant SaaS platform, to cut hospital costs while generating revenue through Remote Therapeutic Monitoring, simultaneously providing integrated, personalized, portable medicine that enables new highly scalable community-wide preventative care systems and value models.

Visit website.

Colin Mansfield
Colin Mansfield, President & CEO
Allheartz

In-Person Presenter
AltaScience

AltaSeal is a minimally invasive, mechanical occlusive permanent contraception device. The device requires no anesthesia, no hormones and is a quick 30 minute procedure placed in the office setting using a standard or disposable hysteroscope.

Visit website.

Gavin Cooper
Gavin Cooper, CEO
AltaScience

In-Person Presenter
Alucent Biomedical

Alucent Biomedical is focused on transforming the way vascular disease is treated. The company is developing a proprietary catheter-based solution called Natural Vascular Scaffolding (NVS). The technology utilizes photoactivation of a small molecule drug delivered endovascularly to create a natural, stent-like scaffold using the body's own tissue and processes.

Visit website.

Myles Greenberg
Myles Greenberg, President & CEO
Alucent Biomedical

In-Person Presenter
Anavasi Diagnostics

Anavasi Diagnostics is a molecular diagnostic company using miniaturized RT-LAMP technology to provide lab-quality molecular diagnostic results in the CLIA-waived / POC environment, and eventually, the home -- in 30 minutes, on average.

Visit website.

Nelson Patterson
Nelson Patterson, CEO
Anavasi Diagnostics

In-Person Presenter
Applaud Medical

Brio is a cavitation-enhanced low-power ultrasound lithotripsy system for office-based kidney stone treatment without anesthesia or fluoroscopy.  The mapping and locating ureteral catheter delivers patented Briosphere microbubbles and ensures beam alignment with the stone. The treatment can be delivered anywhere in a simple, 30-minute procedure. Brio addresses a massive urolithiasis market and huge access and health equity gaps with a reimbursable single use procedure kit.

Visit website.

Paul Molloy
Paul Molloy, CEO
Applaud Medical

In-Person Presenter
AppMed

AppMed's APPY platform is a software solution that allows patients and their healthcare providers to optimize pharmacological treatment strategies for patients with ADHD. The solution computes and visualizes pharmacokinetic profiles of various drug combinations that maximize drug treatments in combination with routinely submitted patient-specific data to optimize patient care.

Visit website.

Louis-Paul Marin
Louis-Paul Marin, CEO
AppMed

In-Person Presenter
Aqua Medical

Treating gastrointestinal disease with disruptive, vapor-based endoscopic ablation therapy.

Visit website.

Lloyd Mencinger
Lloyd Mencinger, President & CEO
Aqua Medical

In-Person Presenter
AquaHeart

Aqua Heart is developing an over-the-wire, single shot ablation solution for the treatment of atrial fibrillation (AFib). The technology combines radiofrequency and balloon elements to bring familiar thermal ablation via a new technique that is a safe and fast way to perform pulmonary vein isolation.

Visit website.

Holger Friedrich
Holger Friedrich, CEO
AquaHeart

In-Person Presenter
ARC Medical

ARC Medical has the only liquid medical device which forms a temporary barrier film to prevent surgical adhesions throughout the entire surgical area. ARC Medical’s products are backed by positive Phase 1 clinical trial safety data in 76 participants and superior nonclinical efficacy data in head-to-head comparisons against 3 of the top marketed products. Surgical indications include gynecological & abdominal and orthopedic surgeries – knee, shoulder & hip.

Visit website.

Chris Springate
Chris Springate, CEO
ARC Medical

In-Person Presenter
Arga Medtech

Arga Medtech is developing a next-generation solution for the treatment of cardiac arrhythmia and atrial fibrillation. The company's Coherent Sine-burst Electroporation (CSE) uses a proprietary puled-field ablation (PFA) generator and catheter to offer a single-shot device capable of producing linear and focal lesions safer, more efficiently and faster than existing technologies used to treat cardiac arrhythmias today.

Visit website.

David Neale
David Neale, CEO & Co-Founder
Arga Medtech

In-Person Presenter
Arrayus Technologies

Arrayus Technologies is developing an image-guided ultrasound platform to enable incisionless therapeutic procedures. The company's technology uses intersecting beams of sonic energy to induce a range of biological effects, including tissue destruction, immunomodulation, drug delivery, and radiosensitization. Arrayus' solution is being developed for a broad range of oncological indications.

Visit website.

James O'Reilly
James O'Reilly, CEO
Arrayus Technologies

In-Person Presenter
Arsenal Medical

Arsenal Medical develops purpose-built biomaterials to solve challenging and underserved medical problems. Our lead products target neurovascular and trauma conditions providing control of blood flow to tumors and hemorrhage. 

Visit website.

Upma Sharma
Upma Sharma, President & CEO
Arsenal Medical

In-Person Presenter
ATRO Medical

ATRO Medical's Artimis prosthesis is intended to provide patients who are too young for a knee replacement yet suffering from chronic knee pain with a viable solution. Artimis is a flexible, artificial meniscus that offers patients a less invasive alternative for treating chronic knee pain.

Visit website.

Maarten van der Zanden
Maarten van der Zanden, CIO
ATRO Medical

In-Person Presenter
Aulisa Medical

Aulisa specializes in the development and commercialization of wearable solutions for continuous remote monitoring of patient vitals. The company's proprietary technology continuously monitors vital signs to identify health incidents prior to them occurring. Rapid spot-checking of patient vitals allows the device to alert providers and parents to health incidents, expanding the window in which appropriate treatment and care can be delivered. The company's flagship product, the Guardian Angel RX system, has been adapted for use in infants, children, and adults.

Visit website.

Augustine Lien
Augustine Lien, CEO
Aulisa Medical

In-Person Presenter
Avisi Technologies

VisiPlate is a nanoscale aqueous shunt that aims to treat mid to late-stage glaucoma.  VisiPlate is 20x thinner than a human hair.

Visit website.

Rui Jing Jiang
Rui Jing Jiang, Founder & CEO
Avisi Technologies

In-Person Presenter
BioCorteX

BioCorteX is a techbio that applies deep technology to deliver effective therapeutics and rewrites Eroom's law by leveraging the synergy between drugs and bacteria. BioCorteX exists because current drug development fails individuals by ignoring the (un)desirable drug-microbiome and pathophysiology-microbiome interactions. The company's lead product, Carbon Mirror™ uses deep tech to simulate how the colossal number of microbiota interact with a drug, de-risking preclinical studies and clinical trials, and replacing uncertainty with confidence for the patient.

Visit website.

Nik Sharma
Nik Sharma, CEO
BioCorteX

In-Person Presenter
Bionic Vision

BVT Bionic Eye System is a suprachoroidal visual implant that has been designed to restore functional vision to the blind suffering from inherited retinal diseases. The Bionic Eye System consists of a retinal implant that receives visual images that are captured, processed, and transferred via a wearable device and processing unit. 

Visit website.

Ash Attia
Ash Attia, CEO
Bionic Vision

In-Person Presenter
BioT Medical

BioT's cloud platform simplifies the creation of a connected care ecosystem. The platform is self-service and requires no coding to connect medical devices, patient management portals, caregivers, and EHRs in an integrated space.

Visit website.

Daniel Adler
Daniel Adler, Co-Founder & CEO
BioT Medical

In-Person Presenter booth icon Innovator Pavilion
Body Vision

Body Vision's fusion imaging platform enables pulmonologists, for the first time, to use all the existing imaging modalities together, in real time, without changing or affecting the procedural flow. The Body Vision System, together with a unique delivery device, enables the physician to plan the procedure, navigate to challenging locations and localize the lesion during biopsy. This complete solution will facilitate early-stage diagnosis of lung cancer and, in addition, will pave the way for minimally invasive transcatheter therapeutics.

Visit website.

David Webster
David Webster, CEO
Body Vision

In-Person Presenter
Bold Type Product Development

Bold Type mission is to help companies solve hard technical problems. The company specializes in transforming proof-of-concepts into protoypes, with a specific emphasis on digital health applications and connected, wireless medical devices.

Visit website.

Jose Bohorquez
Jose Bohorquez, President
Bold Type Product Development

booth icon Innovator Pavilion
BrainSpace

BrainSpace is developing a solution to simplify critical care in neurocritical patients. BrainSpace is committed to improving the way brain pressure is managed in patients recovering from stroke, traumatic brain injury, and neurosurgery. Currently patients requiring intracranial pressure management must be meticulously monitored and measured hourly by a nurse. The company has developed an automated monitoring solution as an alternative to the antiquated drainage monitoring relying on a manometer-based drain and blood pressure monitor that eliminates the hassle for patients and providers while improving the quality of data being captured for researchers and physicians.

Visit website.

Caitlin Morse
Caitlin Morse, CEO
BrainSpace

In-Person Presenter
Caira Surgical

CAIRA is developing software for advanced joint replacement. The software utilizes radar technology to improve navigation during manual and robotic surgery. The company's first product is a navigation system for use during knee replacement surgery.

Visit website.

Jon Greenwald
Jon Greenwald, CEO
Caira Surgical

In-Person Presenter
CairnSurgical

CairnSurgical is developing an innovative tool to guide surgical interventions in patients with cancer. The company's Breast Cancer Locator (BCL) is a proprietary, patient-specific, 3D printed surgical guide intended to reduce positive margins during breast cancer tumor removal. The solution uses MRI data to create a personalized model that assist surgeons in localization and excision of tumors to reduce positive margins.

Visit website.

David Danielsen
David Danielsen, CEO
CairnSurgical

In-Person Presenter
CAPS Medical

CAPS Medical is developing a solution to treat a wide range of solid tumors using Non-thermal Atmospheric Plasma (NTAP). This minimally invasive procedure selectively destroys cancer cells without damaging the surrounding healthy tissue. 

Visit website.

Ilan Uchitel
Ilan Uchitel, CEO & Co-Founder
CAPS Medical

In-Person Presenter
CardiaCare

CardiaCare is developing a closed-loop neuromodulation device for the monitoring and prevention of atrial fibrillation. The wearable device utilizes medical grade artificial intelligence predict and deliver personalized, non-invasive electrical stimulation to the median Vagus nerve to reduce the occurrence of premature atrial contractions that are a precursor to episodes of atrial fibrillation.

Visit website.

Ofer Halbreich
Ofer Halbreich, CEO
CardiaCare

In-Person Presenter
Carecam

Carecam is a digital health startup developing AI-powered solutions to identify gait disorders. The company has created a wearable-free solution that utilizes software and AI vision to analyze a patient's gate for neurology, orthopedic, and rehabilitation practices. 

Visit website.

Elson Yong
Elson Yong, CEO
Carecam

In-Person Presenter
Caresyntax

For industry partners bringing innovative solutions to market: Caresyntax offers clinical data services, data science expertise, and AI-enabled tech modules to collect meaningful data straight from the point of care. The company's services capture value for the end-user and produce actionable insights to drive commercial growth and product development needs.

Visit website.

Bruce Ramshaw
Bruce Ramshaw, Chief Medical Informatics Officer
Caresyntax

In-Person Presenter
Caretaker Medical

Caretaker Medical’s VitalStream™ Wireless Hemodynamic Monitoring platform is FDA-cleared to Non-invasively measure Continuous Beat-by-Beat Blood Pressure, Cardiac Output, Fluid Response, and other Advanced Hemodynamic parameters for ICU-quality continuous Remote Patient Monitoring across the full care continuum.

 The company’s patented Pulse Decomposition Analysis™ AI Technology, wearable Finger Sensor and remote App provide a wire-free alternative to invasive A-Lines and catheter-based hemodynamics and eliminates blind-spots between intermittent measurements to enable early warning of deterioration and guide better clinical decision-making.

Visit website.

Jeff Pompeo
Jeff Pompeo, President & CEO
Caretaker Medical

In-Person Presenter
CARI Health

CARI Health is developing a next-gen wearable remote medication monitoring solution. The device will enable clinicians to view medication levels in real-time, customize dosages for patients, and keep them compliant on life-saving medications. The first application will be for patients being treated with medications for opioid use disorder to ensure treatment compliance remotely, without frequent clinic visits.

Visit website.

Patrik Schmidle
Patrik Schmidle, CEO
CARI Health

In-Person Presenter
CathConnect

Accidental catheter removal can produce significant costs and complications for patients and providers. With nearly 25% of hospitalized patients requiring an indwelling catheter, there is a need for a better solution to prevent burdensome complications associated with these commonly used devices. CathConnect's solution allows existing Foley catheters to be transformed into devices that can easily breakaway without causing complications for patients.

Visit website.

Joelle Tudor
Joelle Tudor, Co-Founder & CEO
CathConnect

In-Person Presenter
Centerline Biomedical

A Cleveland Clinic spinoff company commercializing the Intra-Operative Positioning System (IOPS™) technology — an innovative, non-x-ray based 3D GPS-like surgical navigation technology that improves endovascular procedure outcomes and reduces radiation exposure.

Visit website.

Gulam  Khan
Gulam Khan, CEO
Centerline Biomedical

In-Person Presenter
Centesse

Transforming surgical drainage with intelligent digital devices to reduce complications and costs in patients recovering from cardiothoracic surgery.

Visit website.

Evan Luxon
Evan Luxon, CEO
Centesse

In-Person Presenter
CeQur

CeQur is a medical device company committed to simplifying the lives of people with diabetes by commercializing advanced, simple-to-use insulin-delivery devices that make it easier for people living with diabetes to adhere to therapy and stay in control of their disease. Our product, CeQur Simplicity™, is an injection-free insulin delivery solution backed by years of research, patient trials, and clinical data.

Visit website.

Bradley Paddock
Bradley Paddock, CEO
CeQur

In-Person Presenter
Clarix Imaging

Clarix Imaging is developing a solution to improve the outcomes of cancer surgeries. The company's volumetric specimen imaging system, VSI-360, generates 3D images of specimen in real-time to allow surgical oncologists to visualize tumors in the operating room. The technology allows surgeons and radiologists to visualize specimen margins without overlapping tissues obscuring the margins, and ultimately, improve patient care.

Visit website.

Xiao Han
Xiao Han, CEO
Clarix Imaging

In-Person Presenter
ClearCam

ClearCam develops technologies to improve the visual field-of-view during minimally invasive procedures. The company's ClearScope device is a disposable intra-operative lens cleaning device that continuous cleans and clears the lens of laparoscopic imaging systems during procedures, without having to remove the scope from the body cavity.

Visit website.

John Uecker
John Uecker, CEO
ClearCam

In-Person Presenter
ClearIT

ClearIT is an emerging medtech company developing a new, painless, single treatment for tattoo removal. The company's ERASER System is a non-laser-based approach to tattoo removal. The device dislodges tattoo ink at room temperature through the creation of a benign, safe reactive energy field that works regardless of tattoo or skin color. 

Visit website.

Gordon Nye
Gordon Nye, CEO
ClearIT

In-Person Presenter
Cogentech

Cogentech is driving clinical innovation with LearUp, a secure, private, compliant platform powered by AI and data analytics.

Visit website.

Carlos Granada
Carlos Granada, CEO
Cogentech

In-Person Presenter
Cognoa

Cognoa is a pediatric behavioral health company that is using artificial intelligence (AI) to power digital diagnostic and therapeutic products. The company's lead product, Canvas Dx, is an FDA-authorized diagnostic aid for early autism diagnosis. Other products in development at Cognoa include a therapeutic solution for autism, as well as diagnostic and therapeutic solutions targeted speech disorders, ADHD, and anxiety.

Visit website.

Sharief Taraman
Sharief Taraman, CEO
Cognoa

In-Person Presenter
Cordex Systems

Cordex Systems is developing a novel cardiovascular diagnostic device known as the SmartCuff. It is a quick, simple, non-invasive device that takes the direct measurement of vascular health out of a surgical cardiac catheterization lab and makes it accessible to both a consumer at home and a clinician in the office setting. Known as the “vital vital sign”, the vascular compliance measurement taken by the SmartCuff may be used to track direct changes in vascular health as people engage in healthy lifestyle choices such as diet, exercise, stress reduction and smoking cessation or take prescribed medications to treat diabetes, hypertension, or abnormal lipids.

Kathy Magliato
Kathy Magliato, CEO
Cordex Systems

In-Person Presenter
CorInnova

CorInnova is developing a minimally invasive, soft robotic cardiac device for the short-term treatment of acute heart failure. The device gently conforms to the heart's surface, applying compressions to increase cardiac output without contacting the blood - eliminating a major risk of thrombosis and stroke.

Visit website.

William Altman
William Altman, CEO
CorInnova

In-Person Presenter
CorIT Medical

CorIT Medical is developing a solution targeting the most common patient complaint to ENTs - nasal obstruction. The company's CorIT device is a single-use surgical device for the reduction of inferior turbinates in patients with obstructed breathing. 

Visit website.

Christian Haller
Christian Haller, CEO
CorIT Medical

booth icon Innovator Pavilion
CorNeat Vision

CorNeat Vision has developed a proprietary platform for developing nondegradable, biomimetic biomaterials to treat diseases. The company's EverMAtrix material is a 100% synthetic, nondegradable porous material that mimics the micro-structure of the extracellular matric (ECM). CorNeat's technology has been applied to products for dental and ophthalmic surgery. 

Visit website.

Almog Aley Raz
Almog Aley Raz, CEO
CorNeat Vision

In-Person Presenter
Cosm Medical

Cosm Medical is developing a gynecology platform solution, called Gynethotics, for the treatment of pelvic floor pain. The process involves the use of diagnostic solution to "mold and scan" the pelvic floor.  Artificial intelligence is then used to evaluate and provide clinicians with a personalized prosthetic design that safely integrates within the pelvic floor. Finally, the personalized device is created using 3D printing technology. The Gynethotics' platform will be further supported by a digital health portal to help patients track symptoms and share actionable data with clinicians to improve patient outcomes through the continuum of care.

Visit website.

Derek Sham
Derek Sham, Founder & CEO
Cosm Medical

In-Person Presenter
CVAC

Cyclic Variations in Altitude Conditioning (CVAC) is a is an effort-free method for physical conditioning for individuals of all ages and activity levels to improve fitness. The CVAC process applies precisely composed rhythm-based changes to pressure, temperature and density of air to create waves of tension and relaxation. These changes simulate breathing, muscle contraction, and blow flow changes consistent with circuit, interval and strength training. 

Visit website.

Allen Ruszkowski
Allen Ruszkowski, President & CEO
CVAC

booth icon Innovator Pavilion
Deep Blue Medical Advances

Surgeon-invented T-Line® Hernia Mesh with integral suture-like extensions designed to eliminate a key point of failure for conventional mesh fixation - the mesh, suture, tissue interface - and to provide superior anchor strength. Additional products in development include an anchor clip for even faster, easier implantation; a biosynthetic version of the T-Line Hernia Mesh; and a coated composite version of the T-Line Mesh.

Visit website.

Bill Perry
Bill Perry, CEO
Deep Blue Medical Advances

In-Person Presenter
Delphinus Medical Technologies

Delphinus Medical Technologies develop and commercialize ultrasound technologies specifically for the early detection of breast cancer. The company's flagship product, SoftVue, utilizes proprietary TriAD (triple acoustic detection) technology to capture reflection echoes from all directions around the breast while simultaneously gathering transmitted signals through the breast. SoftVue is specifically designed for use in women with dense breast, who have historically been inadequately served with conventional imaging modalities. 

Visit website.

Scott White
Scott White, CCO
Delphinus Medical Technologies

In-Person Presenter
Diality

Diality is a medical technology company developing a smart hemodialysis platform designed to be as capable and flexible as in-center treatment, in a fully integrated, easy-to-use system that’s intended to be safe to operate in any environment, with enough versatility to allow healthcare providers to tailor treatment to each patient’s specific needs. The Diality Hemodialysis System’s compact footprint and mobility are intended to enable it to be easily integrated into – and transported within – any dialysis setting, be it acute-care hospital, dialysis clinic, transitional care unit, traditional home, or skilled nursing facility.

Visit website.

Osman Khawar
Osman Khawar, CEO
Diality

booth icon Innovator Pavilion
Dilon Technologies

Dilon Technologies develops a wide range of innovative medical solutions to benefit patients around the world. The company's portfolio of products ranges from devices to support surgical oncologists to ensure successful tumor localization and removal, to devices to improve intubation and hemostasis.

Visit website.

George Makhoul
George Makhoul, CEO
Dilon Technologies

In-Person Presenter
DriQ Health

DriQ Health is an internet-of-things (IoT) incontinence monitoring solution. The company's technology leverages sensor technology and artificial intelligence to monitor the state of a diaper or adult brief. DriQ Health provides end-users with real-time access to their data to providers work with their patients to improve their quality of life.

Visit website.

Gregory Dean
Gregory Dean, CEO & Founder
DriQ Health

In-Person Presenter booth icon Innovator Pavilion
Echopoint Medical

Echopoint Medical is developing a family of optical-fiber based sensors which integrate into microcatheters to guide and improve outcomes during interventional cardiology procedures. The company's iKor platform translates ultrasonic signals to measure blood pressure and flow to more accurately assess, diagnose and treat patients with coronary artery disease and coronary microvascular dysfunction. 

Visit website.

Antony Odell
Antony Odell, CEO
Echopoint Medical

In-Person Presenter
Egg Medical

Egg Medical was founded in 2014 to develop and market the next generation of radiation protection devices for hospital x-ray labs. The company's first product, the Egg Nest, reduces staff radiation exposure by >90%! We launched commercial sales in late 2019- and the R&D and commercial buildout continues.

Visit website.

Robert Wilson
Robert Wilson, CEO
Egg Medical

In-Person Presenter
Elixir Medical

Elixir Medical mission is to breathe new life into vascular interventions. To achieve said mission, the company is pursuing the development of its latest product, the DynamX Coronary Bioadaptor System. DynamX is designed to be a significant advancement compared to drug-eluting stents in patients with symptomatic ischemic heart disease. Other vascular interventions in development at Elixir include a site-specific antithrombotic therapy and a lithotripsy system to effectively manage calcium buildup. 

Visit website.

Motasim Sirhan
Motasim Sirhan, CEO
Elixir Medical

In-Person Presenter
Endologix

Endologix is dedicated to improving patients' lives through innovative interventions for the treatment of vascular disease. The company's portfolio consists of novel products for the treatment of peripheral artery disease (PAD) and aortic aneurysm repair (EVAR).

Visit website.

Matthew Thompson
Matthew Thompson, President & CEO
Endologix

In-Person Presenter
EP Solutions

EP Solutions is improving clinical outcomes in cardiac resynchronization therapy cases through the use of noninvasive cardiac mapping technology. The company's Amycard 01C is an electrophysiology workstation that records body surface electrograms to create optimized 3D heart models that merge ECG data with anatomical data obtained from medical imaging. EP Solutions' technology helps physicians accurately place CRT leads during implantation and optimize devices during follow-up visits.

Visit website.

Marcin Golebicki
Marcin Golebicki, CEO
EP Solutions

In-Person Presenter
Ergosuture

Surgical solutions that help improve suturing safety, speed and versatility.

Visit website.

Claude Nogard
Claude Nogard, CEO
Ergosuture

In-Person Presenter
eXpanded eXistence

eXpanded eXistence HoloOPS platform combines mixed reality technology with artificial intelligence to optimize the surgical suite. The platform provides surgeons with on-demand access to data and visualizations previously inaccessible to them from within the OR.

Visit website.

Robert Masson
Robert Masson, CEO & Founder
eXpanded eXistence

In-Person Presenter
Facet Dynamics

Facet Dynamics is developing a next generation alternative to lumbar fusion procedures. Protected by 4 U.S. Patents, “Restore” is a unilateral lumbar facet replacement device, manufactured from the same materials used in today’s artificial hip and knee joints, and implanted in exactly the same fashion as that which occurs in contemporary lumbar fusion procedures. 

Chris Sturm
Chris Sturm, President
Facet Dynamics

In-Person Presenter
FibriCheck

FibriCheck combines photoplethysmography (PPG) and a smartphone to transform the way atrial fibrillation is detected and monitored. A medically certified algorithm processes the image captured data and obtain insights on heart rhythm as an alternative to electrocardiogram-based devices. 

Visit website.

Lars Grieten
Lars Grieten, CEO
FibriCheck

In-Person Presenter
Field Medical

Field Medical is developing a next-generation pulsed field ablation (PFA) solution for the treatment of cardiac arrhythmia. The company is building a purpose-built system that incorporates PFA, contact force sensing, electromagnetic localization, and artificial intelligence-enabled mapping capabilities to address the limitations of first-generation PFA technologies and deliver more efficacious therapy. 

Visit website.

Steven Mickelsen
Steven Mickelsen, CEO
Field Medical

booth icon Innovator Pavilion
Fifth Eye

 

Visit website.

Andrew Malcolmson
Andrew Malcolmson, CEO
Fifth Eye

In-Person Presenter
FIZE Medical

FIZE Medical is developing a patient monitoring platform to measure the health status of patients based off real-time analysis of urine output. The company is currently developing three products that are all based around the base iUO monitoring device. The iUO Plus and iUO DUOFLO are advanced iterations of the base model model, enabling monitoring of acute kidney injury, shock prediction, intraabdominal pressure monitoring, and other vital monitoring measures.

Visit website.

Dror Zerem
Dror Zerem, CEO
FIZE Medical

In-Person Presenter
Flow Medical

Flow Medical is developing a novel thrombolytic catheter for the treatment of pulmonary embolism. The device will combine imaging, infusion, and monitoring into a single solution to streamline procedures, improve therapeutic efficacy, and reduce inventory needs.

Visit website.

Jennifer Fried
Jennifer Fried, CEO
Flow Medical

In-Person Presenter
Fluid Biomed

Fluid Biomed is a VC-backed pre-clinical medical device start-up that has developed the world’s first bio-resorbable stent to cure brain aneurysms. The company's innovative polymer technology allows physicians the versatility of treating a wider variety of aneurysms more safely and efficiently. 

Visit website.

John Wong
John Wong, Co-Founder & CEO
Fluid Biomed

In-Person Presenter
FluidAI

FluidAI is developing smart monitoring solutions to detect anastomotic postoperative complications early. The company's plug-and-play technology integrates seamlessly with existing peritoneal drains and catheters to provide physicians with active patient monitoring of leakage-related surgical complications.

Visit website.

Youssef Helwa
Youssef Helwa, CEO
FluidAI

In-Person Presenter
FundamentalVR

Accelerating surgical capability for life science businesses via precision VR simulation.

Visit website.

Richard Vincent
Richard Vincent, Founder & CEO
FundamentalVR

In-Person Presenter
GT Medical Technologies

GT Medical's GammaTile Therapy is a targeted approach for delivering radiation to brain tumor cells. The company's technology minimizes complication while optimizes therapeutic efficacy. Placed by a neurosurgeon during resection, GammeTile's provide uniform radiation-source spacing to ensure even dose distribution. 

Visit website.

Shane Brown
Shane Brown, Chief Commercial Officer
GT Medical Technologies

In-Person Presenter
Gyder Surgical

Gyder Surgical's Gyder Hip System is a non-invasive, pin-less navigation solution for total hip replacement. The system is an open platform that can be used with a surgeon's preferred implant system, reduces radiation exposure by not requiring CT or X-ray imaging, and seamlessly integrates into existing workflows due to the system's simple set-up and quick calibration.

Visit website.

Sujit Dike
Sujit Dike, CEO
Gyder Surgical

In-Person Presenter
HAPPE Spine

HAPPE Spine LLC, is a medical device development company that designs and commercializes innovative spinal implants utilizing the patented HydroxyApatite Porous PolyEtheretherketone (HAPPE TM ) material platform. This technology combines the benefits  of hydroxyapatite for bone ongrowth, designed porosity for bone ingrowth, and the radiolucency of PEEK for post-operative radiographic assessment.

Visit website.

Andrew Iott
Andrew Iott, CEO
HAPPE Spine

In-Person Presenter
Harmonic Bionics

Harmonic Bionics is a robotics company developing exoskeleton solutions to improve and rehabilitate movement impairments due to neurological and musculoskeletal disorders. The company's lead product, Harmony SHR, is a bilateral, upper-extremity exoskeleton designed to optimize upper-extremity rehabilitation.

Visit website.

Mark Hunter
Mark Hunter, CEO
Harmonic Bionics

In-Person Presenter
HidraMed Solutions

Hidradenitis Suppurativa (HS) is an inflammatory skin disease that causes painful symptoms, particularly in difficult to cover parts of the body such as the armpits, buttocks and groin. Traditional dressings often fail to provide adequate protection, cause additional skin damage via adhesives, and are challenging for patients to apply. HidraWear is a wearable wound care system that provides HS patients with the necessary support to easily apply and manage their flares.

Visit website.

Suzanne Moloney
Suzanne Moloney, CEO
HidraMed Solutions

In-Person Presenter
Hy2Care

Hy2Care's vision is to support patients in the fight against osteoarthritis. The company's lead product, CartRevive, is a hydrogel implant composed of dextran and hyaluronic acid conjugates that form a resorbable scaffold when injected. The hydrogel enables natural restoration of tissue defects by creating an environment conducive to cell regrowth that proceeds towards the restoration of smooth hyaline cartilage. 

Visit website.

Leo Smit
Leo Smit, CEO
Hy2Care

In-Person Presenter
iChor Vascular

iChor Vascular's goal is to become the 1st-line therapy for treating peripheral vascular occlusions. The company's ICHOR Panacea technology is a versatile, catheter-based solution that provides rapid reperfusion to occluded vessels, without the need for thrombolytic drug therapies or complex surgery. 

Visit website.

Timothy Blair
Timothy Blair, President
iChor Vascular

In-Person Presenter
iiSheild

iiShield's mission is to improve short and longterm transplant outcomes. The company's lead product is a protective jacket for the kidney that aims to increase the amount working time available to surgeons during transplant procedures. The device protects kidneys from heating up during surgery, reducing the amount of thermal injury to these vital organs and minimizing risks of complications.

Visit website.

Jeremy Kwarcinski
Jeremy Kwarcinski, CEO
iiSheild

In-Person Presenter
ImaCor

ImaCor designs, manufactures, and distributes a hTEE (hemodynamic transesophageal echocardiography) ultrasound system to enable clinicians to optimize cardiac interventions by enabling clinicians to guide and assess the effectiveness of therapies and make critical changes to patient management at the right time. 

Visit website.

Scott Roth
Scott Roth, CEO
ImaCor

In-Person Presenter
inHeart

inHeart's technology generates a 3D map of the patient's heart from medical images to provide physicians with a highly detailed anatomical map, including structural substrate for both ventricles and atria.

Visit website.

Todor Jeliaskov
Todor Jeliaskov, CEO & Chairman
inHeart

In-Person Presenter
InkSpace Imaging

InkSpace Imaging pioneers a transformative printed electronics platform, initially prioritizing advanced MRI receive coils. These lightweight and flexible coils not only elevate diagnostic imaging, revealing the once invisible, but also expedite scans, enhance patient experiences, reduce the need for sedation, and minimize procedures. Compatible with existing MRI systems and healthcare reimbursement structures, the company's FDA-cleared innovation represents a next-generation approach to accessible, high-quality diagnostics.

Visit website.

Peter Fischer
Peter Fischer, CEO
InkSpace Imaging

In-Person Presenter booth icon Innovator Pavilion
Innova Vascular

Innova Vascular develops medical devices for the treatment of thromboembolism. The company's portfolio of vascular interventions include aspiration catheters and clot retrievers for the treatment of arterial and venous thromboembolism.

Visit website.

Sanjay Shrivastava
Sanjay Shrivastava, CEO
Innova Vascular

In-Person Presenter
INNOVENTRIC

Innoventric id developing an easy-to-use, reliable, and safe percutaneous solution for the treatment of tricuspid regurgitation. The company's Trillium device uses cross-caval anchoring and a unique, multi-valve design to fit a wide range of anatomies without the risks of migration and leaks. 

Visit website.

Amir Danino
Amir Danino, Founder & CEO
INNOVENTRIC

In-Person Presenter
Interventional Systems

Interventional Systems is improving patient outcomes by expanding access to minimally invasive robotics. The company's miniature robotic platform, Micromate, is designed to support interventional radiologists and oncologists with an easy-to-mount system that integrates into existing operating rooms. The Micromate platform offers single and multi-needle, device agnostic interventions supported by the submillimeter accuracy and corrective capabilities of robotics.

Visit website.

Pedro Costa
Pedro Costa, CEO
Interventional Systems

In-Person Presenter
IntraOp Medical

IntraOp Medical is focused on the development and commercialization of portable electron-beam intraoperative radiation therapy (IORT) systems. The company's flagship product, Mobetron, is a mobile, self-shielded LINAC machine for treatment of cancer patients during surgery.

Visit website.

Sanjay Arora
Sanjay Arora, CEO
IntraOp Medical

In-Person Presenter
Invenio Imaging

INVENIO's NIO Laser Imaging system uses Stimulated Raman Histology to image unprocessed tissue specimen without requiring sample preparation to enable histological evaluation of tissue outside of a laboratory. 

Visit website.

Jay Trautman
Jay Trautman, Co-Founder, CEO & Director
Invenio Imaging

In-Person Presenter
InVera Medical

InVera Medical is developing a catheter-based therapy for chronic venous disease.  The device uses non-thermal energy to disrupts the inner vessel lining, resulting in natural scarring and vessel closure that diverts blood flow away from diseased vessels.

Visit website.

In-Person Presenter
IQ Endoscopes

At IQ Endoscopes, we are creating pioneering, sustainable endoscopy technologies for the early diagnosis of diseases, helping to create a world where everyone has access to sustainable sterile endoscopy. Our Single Use Gastroscope is currently under regulatory review and this will be quickly followed by regulatory submissions for our single use colonoscope and sigmoidoscope in 2024. This compelling platform will enable IQ Endoscopes to offer healthcare professionals the most comprehensive range of single use technology to address the Gastro Intestinal market, whilst also ensuring key sustainability requirements are surpassed. With commercial activities set to begin in 2025, the organization is at a very exciting stage.

Visit website.

Matt Ginn
Matt Ginn, CEO
IQ Endoscopes

In-Person Presenter
Jana Care

Jana Care is developing self-administered testing technologies for chronic kidney, heart disease, and diabetes management. The platform enables patients to self-administer blood tests at home, and clinicians can remotely review the test results as needed. The platform’s capabilities aim to overcome distance and socioeconomic hurdles that currently hinder the timely detection and monitoring of chronic kidney and heart disease progression.

Visit website.

Anh Hoang-Lindsay
Anh Hoang-Lindsay, CEO
Jana Care

In-Person Presenter
JelikaLite

JelikaLite is a clinical stage medtech company developing a neuromodulation platform that addresses unmet needs in developmental pediatric disorders. The company's Cognilum device is a wearable therapeutic device that provides non-invasive brain stimulation using near-infrared light to improve responsiveness, speech, and social interaction in children with autism.

Visit website.

Katya Sverdlov
Katya Sverdlov, CEO
JelikaLite

In-Person Presenter
Joint Preservation Innovations

Joint Preservation Innovations (JPI) is proud to present the Articulator Bone Resector, a novel arthroscopic articulating bone resection tool. Developed over 7 years with input from leading surgeons along with automotive, aerospace and medical device engineers, Articulator gives minimally invasive surgeons the freedom to finally articulate rotary cutting tools for bone resection in a manner never before possible. Awarded an FDA Breakthrough Device Designation in 2023, Articulator aims to reduce the surgical footprint of various musculoskeletal procedures, including large market applications in arthroscopic, endoscopic spinal and robotic surgery.

Visit website.

Sanjeev Bhatia
Sanjeev Bhatia, CEO
Joint Preservation Innovations

In-Person Presenter
KelaHealth

The annual cost of avoidable complications to the entire U.S. healthcare system is $45 billion. KelaHealth has developed a software-as-a-service (SaaS) solution designed to address this problem by accurately predicting who will develop surgical complications and connecting the patient's risks with evidence-based interventions, helping surgeons to adopt actions that prevent complications after surgery. The company's platform uses applied artificial intelligence and big data analytics, to accurately predict and build a personalized report for each patient, for each procedure.

Visit website.

Bora Chang
Bora Chang, Founder & CEO
KelaHealth

In-Person Presenter
Kent Imaging

Kent Imaging is using multispectral oxygenation imaging to enhance the care of chronic wounds. The company's lead product, SnapshotNIR, is a portable tool that utilizes near-infrared (NIR), reflectance-based technology to measure tissue oxygen saturation in superficial tissue. The information collected by the device improves the data available to care providers when making medical decisions that positively impact patient outcomes in wound care.

Visit website.

Pierre Lemire
Pierre Lemire, CEO
Kent Imaging

In-Person Presenter
Kneevoice

Kneevoice has designed a platform technology to capture the noise generated by the knee to evaluate cartilage damage and diagnose osteoarthritis. The platform consists of wearable knee sensors that records the sounds generated by the knee. This data is collected an analyzed by a neural network algorithm and generates a score evaluating the status of the cartilage.

Visit website.

Gustavo De Greiff
Gustavo De Greiff, CEO
Kneevoice

In-Person Presenter
Lazurite

Lazurite's ArthroFree system is a wireless surgical camera designed to address the limitations of traditional arthroscopic camera systems. Lazurite's technology removes the need for fiber-optic cables, helping to improve efficiency without compromising image quality. At the heart of the company's technology is the proprietary Meridiem light engine, a novel light source that does not require cables to transmit light and images during surgical procedures. 

Visit website.

Leah Brownlee
Leah Brownlee, President
Lazurite

In-Person Presenter
Lazzaro Medical

Lazzaro Medical has developed a minimally invasive surgery for the treatment of Tracheobronchomalacia (TBM), a degenerative disease that causes the complete, or near-complete, collapse of the airway due to cartilage breakdown in the trachea. The LM Scaffold System restores the patency of the trachea, improving breathing through a simple procedure conducted via a robotic system. The company is pursuing a platform approach to the treatment of TBM and other pipeline indications with the development of a diagnostic tool to simplify diagnosis and an endotracheal tube to improve the efficiency of respiratory surgeries.

Visit website.

Dawn Bitz
Dawn Bitz, President
Lazzaro Medical

In-Person Presenter booth icon Innovator Pavilion
Leadoptik

LEADOPTIK is developing an image-guided biopsy needle for early-stage lung cancer detection. Clinical challenges persist in integrating technology and tools to safely and effectively reach the peripheral lung. The company is introducing metasurface technology to caregivers, enabling real-time nodule assessment (RTNA) during biopsies.

Visit website.

Reza Khorasaninejad
Reza Khorasaninejad, CEO
Leadoptik

In-Person Presenter
LifeSignals

Supporting the development of wearable microsensors for the measuresment of biometric signals. LifeSignals works with companies to develop health and wellness monitoring solutions with their portfolio of patented hardware and software.

Visit website.

Surendar Magar
Surendar Magar, CEO
LifeSignals

In-Person Presenter
LINLINE Medical Systems

LINLINE Medical Systems has over two decades of experience in the design and production of medical lasers. The company's flagship product, MULTILINE, is a multi-application, modular platform equipped with five external high-intensity lasers intended for use in aesthetics, dermatology, and surgery. 

Visit website.

Alex Troshkin
Alex Troshkin, Co-Founder
LINLINE Medical Systems

In-Person Presenter booth icon Innovator Pavilion
Linshom Medical

Linshom (“to breathe”) is first to deliver an Operating Room quality respiratory profile to the patient bedside and home for continuous, predictive respiratory monitoring (CPRM). Our FDA cleared device provides a full respiratory profile delivered continuously and in real time to predict and intercept respiratory decline before an emergency develops.

Visit website.

Richard Hughen
Richard Hughen, CEO
Linshom Medical

In-Person Presenter
Lionheart Health

Lionheart Health is using targeted bioelectric treatment to stimulate the body's natural healing and regeneration. Specific bioelectric signaling sequences have been shown to promote the expression of proteins for cosmetic purposes, as well as in pathways related to brain, muscle and nerve regeneration. The core stimulation technology has been purposefully implemented into a number of wearable devices targeting specific clinical indications. 

Visit website.

Howard Leonhardt
Howard Leonhardt, CEO
Lionheart Health

In-Person Presenter
Liquet Medical

Liquet Medical's mission is to transform the way vascular disease is treated. The Versus Catheter features dual tips that enables treatment of both lungs, in addition to real-time pressure monitoring sensors which allows physicians to optimize the amount of drug delivered while limiting potential side effects.

Visit website

John Schindler
John Schindler, CEO
Liquet Medical

In-Person Presenter
Lucid Diagnostics

Lucid is developing solutions to help clinicians diagnose and manage the progression of esophageal disease. The company has developed to solutions that allow clinicians to effortlessly collect and analyze esophageal cells to identify Barrett's Esophagus.

Visit website.

Lishan Aklog
Lishan Aklog, CEO
Lucid Diagnostics

In-Person Presenter
Lumicell

Lumicell is focused on innovative fluorescence-guided technologies for cancer surgery. The company's Lumicell Direct Visualization System is intended to guide the removal of residual cancer during surgery in real time. The platform technology consists of an optical imaging agent, a handheld device, and patient-calibrated tumor detection software that work together to find, view and guide the resection of residual cancer. Lumicell is currently investigating the use of its technology for use during breast cancer surgery.

Visit website.

Kevin Hershberger
Kevin Hershberger, CEO
Lumicell

In-Person Presenter
Lumiheal Therapeutics

Lumiheal Therapeutics is harnessing the power of fluorescent light energy to heal chronic and acute wounds, burns and surgical incisions.  Our mission is to make highly effective advanced wound therapies affordable and accessible to all.

Visit website.

Howard Walthall
Howard Walthall, Founder & CEO
Lumiheal Therapeutics

In-Person Presenter
Lungpacer Medical

Lungpacer Medical is focused on empowering patients to breathe on their own following mechanical ventilation. The AeroPace System harnesses the body's nervous system via catheter-based stimulation of the phrenic nerves to rebuild diaphragm muscle strength and wean patients off ventilators faster. 

Visit website.

Doug Evans
Doug Evans, President & CEO
Lungpacer Medical

In-Person Presenter
Magenta Medical

Magenta Medical is developing miniaturized solutions for the treatment of acute and chronic heart failure. The company's lead product, Elevate, is a percutaneous Left Ventricular Assist Device (pLVAD) is a self-expanding, catheter-mounted arterial pump comprised of a thin memory-shape metallic frame and a soft, flexible material that forms the body of the blades. The device is intended to provide temporary mechanical circulatory support for the left ventricle.

Visit website.

David Israeli
David Israeli, CEO
Magenta Medical

In-Person Presenter
MALCOVA

MALCOVA is utilizing proprietary computed tomography technology to provide a safe, comfortable, and effective imaging solution for the early detection and diagnosis of breast cancer, particularly in women with dense breasts. This technology is at the heart of a three-pronged approach that leverages the company’s advances in hardware, AI-based software, and patient-surrogate phantoms to yield a significant paradigm shift in the way breast cancer is detected and treated.

Visit website.

Tara Ghazi
Tara Ghazi, Co-Founder & COO
MALCOVA

In-Person Presenter
Medical 21

Developing an artificial artery to eliminate the harvesting of vessels from the patient during bypass CABG surgery.

Visit website.

Manny Villafana
Manny Villafana, CEO
Medical 21

In-Person Presenter
Method AI

Method AI is developing a surgical navigation platform to drive improved patient outcomes for robotic oncology procedures.  The company’s product will leverage deep tissue imaging and machine learning algorithms to provide physicians with real-time guidance against an AI-generated surgical plan.

Visit website.

Doug Teany
Doug Teany, Co-Founder & CEO
Method AI

In-Person Presenter
MicroTransponder

MicroTransponder's Vivistim tool treats patients who experience upper limb problems after a stroke by delivering a small amount of neurostimulation to the vagus nerve to strengthen neural pathways in the brain during rehabilitation. The device comprises a small implanted battery and wires that internally connect to the vagus nerve in the neck. In addition to the Vivistim system, the company is evaluating its Serenity system as a treatment to treat and reduce tinnitus over time. 

Visit website.

Richard Foust
Richard Foust, CEO
MicroTransponder

In-Person Presenter
MIMOSA Diagnostics

MIMOSA has developed a tiny, hand-held device that democratizes the collection of tissue information in patients with peripheral vascular disease (PVD), wound care, diabetes, burns, and potential post-operative surgical complications. The device is capable of detecting tissue oximetry and temperature through the use of multispectral imaging, letting healthcare providers visualize beneath the skin, regardless of the patient's location.

Visit website.

Dr. Karen Cross
Dr. Karen Cross, Co-Founder & CEO
MIMOSA Diagnostics

In-Person Presenter booth icon Innovator Pavilion
Modulim

Modulim’s mission is to help clinicians prevent the onset or escalation of diabetic foot ulcers—and other complications of vascular compromise. The Clarifi device is a noninvasive, non-contact, diagnostic wide-field imaging system that provides a fast, reliable, and objective method of assessing tissue oxygen saturation, hemoglobin quantity, and distribution at different depths in patients with compromised circulation.

Visit website.

Amaan Mazhar
Amaan Mazhar, CEO
Modulim

In-Person Presenter
MOLLI Surgical

MOLLI Surgical started in the OR after recognizing that surgeons were using dated technologies to treat cancer patients. The company's technology eliminates the need for wires and radioactive seeds for tumor localization with a magnetic-based system that is precise, reliable, and easy-to-use.

Visit website.

Ananth Ravi
Ananth Ravi, CEO & Co-Founder
MOLLI Surgical

In-Person Presenter
MultipIAI Health

Visit website.

Meg Samek-Smith
Meg Samek-Smith, CRO
MultipIAI Health

In-Person Presenter
MY01

MY01 has developed a device to continuously monitor and manage acute compartment syndrome in muscles. The MY01 device is a sterile, single-use device that quickly measures muscle pressure following orthopedic surgery for trauma.

Visit website.

Charles Allan
Charles Allan, CEO
MY01

In-Person Presenter
N8 Medical

N8 Medical is incorporating active compounds called ceragenins into medical devices to address unmet needs in patient care related to infections and other complications associated with medical devices. The company's lead product, CeraShield, is a biofilm-resistant endotracheal tube designed to reduce ventilator associated respiratory infections. N8 plans to employ the use of ceragenins into other medical devices that can benefit from the antimicrobial and anti-inflammatory properties of these small molecules. 

Visite website.

Bob Mitchell
Bob Mitchell, CEO
N8 Medical

In-Person Presenter
Nanoflex Robotics

Nanoflex Robotics is developing next-generation, remote robotic solutions to enhance access to life-saving procedures. The company's robotic system uses advanced magnetic technology and ultra-flexible endoluminal tools to enable faster and easier navigation through tortuous blood vessels. Nanoflex's initial target application aims to shorten the time to treatment for acute ischemic stroke by making remote mechanical thrombectomies a reality.

Visit website.

Matt Curran
Matt Curran, CEO
Nanoflex Robotics

In-Person Presenter
NanoHive

NanoHive's proprietary spinal fusion Soft Titanium technology addresses the challenges of spinal fusion with a bioactive, 3D-printed, titanium interbody device. The design of the device grants it the flexibility of PEEK while providing similar load bearing strength comparable to bone. 

Visit website.

Patrick O'Donnell
Patrick O'Donnell, President & CEO
NanoHive

In-Person Presenter
NasaClip

NasaClip is an adjustable nosebleed rescue device designed to provide constant, comfortable, hands-free compression. The NasaClip device combines intranasal sponges and external nasal pressure to compliment and support the body's natural clotting process. 

Visit website.

Elizabeth Clayborne
Elizabeth Clayborne, CEO
NasaClip

In-Person Presenter
Navigation Sciences

Navigation Sciences™ is a clinical-stage company developing the NaviSci™ System for the tissue conserving removal of lung cancer and other soft tissue tumors. The system integrates Augmented Reality (AR) and advanced software with surgical hardware to guide precise surgical resection by enabling for the first time, real-time in-vivo margin measurement.

Visit website.

Alan Lucas
Alan Lucas, CEO & Co-Founder
Navigation Sciences

In-Person Presenter
NeuEsse

Plant-based human skin substitute in either a protein material bandage or a "no-touch" application protocol device (especially for burns) that is lightweight, portable, military-grade and available at any point of injury to deliver skin substitutes along with other therapeutics for military and civilian patients.

Visit website.

Joseph Connell
Joseph Connell, CEO
NeuEsse

In-Person Presenter
Neuralace Medical

NeuraLace Medical are the developer's of Axon Therapy, an FDA-cleared solution for the management of chronic pain. Axon Therapy uses noninvasive, magnetic pulse technology to treat chronic nerve pain in patients recovery from injury or surgical procedures.

Visit website.

Keith Warner
Keith Warner, CEO
Neuralace Medical

In-Person Presenter
Neuro42

Neuro42 is developing a point-of-care, portable MRI platform backed by artificial intelligence and robotics. The platform will utilize low-field MRI imaging technology to enable imaging across departments, as well as support surgical procedures with live image guidance. 

Visit website.

Abhita Batra
Abhita Batra, Founder & CSO
Neuro42

In-Person Presenter
Neuronoff

Neuronoff is developing an injectable electrode platform that is an adaptive, minimally invasive technology that transforms complex neuromodulation procedures into simple outpatient procedures. The Injectrode technology enables the electrical stimulation of hard to reach nerves and tissues using an 18 ga needle and self-anchor to prevent lead migration.

Visit website.

Manfred Franke
Manfred Franke, CEO
Neuronoff

In-Person Presenter
NirvaMed

NirvaMed is an early-stage medtech company developing a novel treatment for ST-Elevation Myocardial Infarction (STEMI). The company's solution is a rapid cooling system that can be deployed in parallel with standard devices for PCI to enable cardiac tissue preservation that addresses the shortcomings of previous hypothermic treatments. The device is delivered to the right side of the heart to prevent disruptions to standard left side of the heart procedures to provide ischemic relief prior to reperfusion therapy.

Visit website.

Pramote Hochareon
Pramote Hochareon, Founder & CEO
NirvaMed

In-Person Presenter
NovaResp Technologies

NovaResp is developing technology to improve the prediction of respiratory events in patients using positive airway pressure (PAP) machines. The company's platform uses artificial intelligence and machine learning to monitor respiration and prevent detrimental episodes of apnea. 

Visit website.

Hamed Hanafi
Hamed Hanafi, CEO
NovaResp Technologies

In-Person Presenter
Novian Health

Novian Health has developed a laser-based system for the treatment of tumors. The technology is intended to be a minimally invasive alternative to surgery in select cancerous and non-cancerous tumors. Novian has received the CE Mark for the treatment of malignant and benign breast tumors. The company's Novilase technology is currently cleared in the US for the treatment of benign breast tumors and soft tissue ablation.

Visit website.

Henry (Chip) Appelbaum
Henry (Chip) Appelbaum, President & CEO
Novian Health

In-Person Presenter
Novuson Surgical

Novuson’s patented DTU technology will represent the first substantive innovation in over 25 years for targeting vessel sealing / dividing, and hemostasis (bleeding control) in surgical and trauma applications.

Visit website.

Stuart Mitchell
Stuart Mitchell, CEO
Novuson Surgical

In-Person Presenter
NOxy Health Products

NOxy Health Products is a healthcare company driven to developing innovative medicines that harness the natural restorative capabilities of nitric oxide (NO) to heal chronic wounds. Due to various factors, the body can lack the natural ability to produce and deliver sufficient NO. The company is investigating topical means to deliver NO exogenously to improve oxygen and nutrient flow to wounds, promote healthy inflammation, and stimulate the development of new microvessels and tissue.

Visit website.

Tim Jacobson
Tim Jacobson, CEO
NOxy Health Products

In-Person Presenter
Nurami Medical

Nurami Medical is a developer of soft tissue repair technologies that leverage the company's expertise in brain physiology, nanofibers, and biomaterials. Nurami's technology utilizes a combination of electrospun nanofiber scaffolds and advanced bioactive materials. The company's flagship product, ArtiFascia, is a synthetic dural graft intended to facilitate the healing of the dura after cranial neurosurgery by creating an effective barrier that prevents harmful CSF leaks in dura repairs. 

Visit website.

Peter Stebbins
Peter Stebbins, Executive Chair of the Board
Nurami Medical

In-Person Presenter
Nutromics

Nutromics is pioneering Continuous Molecular Monitoring (CMM), a real-time biomarker monitoring platform that offers molecular patient data. The technology integrates into a wearable smart patch that continuously captures and transmits data to mobile and web-based applications for easy integration with hospital and consumer health software. 

Visit website.

Peter Vranes
Peter Vranes, CEO
Nutromics

In-Person Presenter
Nuubo

Nuubo is a textile electrode for mid- to long-term ECG monitoring. The Nuubo system simplifies collection of ECG data compared to traditional, wire-based systems. Composed of a flexible material that adapts to the wearer's movements, Nuubo does not restrict daily physical activities and enables the capture of new cardiac insights based on the expanded range of physical data available to clinicians.

Visit website.

Juan Alcantara
Juan Alcantara, CEO
Nuubo

In-Person Presenter
NXgenPort

Implantable ports are at increased risk of complications that cost healthcare systems and patients over $2 billion dollars annually. To address the challenges inherent to implantable ports, NXgenPort have developed a smart port that remotely monitors and reports physiological changes in vivo. The device enables better patient management and early intervention, and ultimately, better clinical outcomes.

Visit website.

Cathy Skinner
Cathy Skinner, CEO
NXgenPort

In-Person Presenter
OnPoint Surgical

OnPoint Surgical is revolutionizing orthopedic and neurosurgical spinal procedures with an Augmented Reality (AR) platform technology that superimposes virtual surgical guides and virtual spinal implants onto the surgeon’s visual field using see-through optical head-mounted displays. The technology offers many unique clinical and intra-operative benefits including intuitive use, improved hand-eye coordination, and impressive accuracy with the potential for better clinical outcomes.

Visit website.

Philipp Lang
Philipp Lang, Chairman & CEO
OnPoint Surgical

In-Person Presenter
Opsin Biotherapeutics

Opsin Biotherapeutics is a joint venture that combines the expertise of Nanoscope Technologies with DesignPlex Biomedical to create unique products and alternatives to opioids and spinal cord stimulation for the treatment of chronic pain. Opsin's therapy specifically targets and activates the neurons that block pain through the delivery of light sensitive proteins that are activated via a low power LED light.

Visit website.

Robert Benkowski
Robert Benkowski, Co-Founder & CEO
Opsin Biotherapeutics

In-Person Presenter
Orthomod

Orthomod's mission is to develop the next generation of orthopedic biomaterials. The company is combining natural and synthetic orthobiologics with polymer components to create implants for orthopedic and spinal surgery. 

Visit website.

David Kirschman
David Kirschman, Co-Founder
Orthomod

In-Person Presenter
Osman Khawar

Diality is a medical technology company developing a smart hemodialysis platform designed to be as capable and flexible as in-center treatment, in a fully integrated, easy-to-use system that’s intended to be safe to operate in any environment, with enough versatility to allow healthcare providers to tailor treatment to each patient’s specific needs. The Diality Hemodialysis System’s compact footprint and mobility are intended to enable it to be easily integrated into – and transported within – any dialysis setting, be it acute-care hospital, dialysis clinic, transitional care unit, traditional home, or skilled nursing facility.

Visit website.

Osman Khawar
Osman Khawar, CEO
Osman Khawar

In-Person Presenter
Ossiform

Ossiform uses proprietary technology to 3D print patient-specific, natural, and resorbable bone implants. P3D Bone PSI is a fully resorbable bone graft substitute that features a unique bone-like porosity that remodels in real living bone. P3D Bone demonstrates osteoconduction with the rapid formation of new vascularized bone that osseointegrates with native bone, while simultaneously balancing bioresorption. 

Visit website.

Monica Wellejus
Monica Wellejus, Sales and Marketing Manager
Ossiform

In-Person Presenter
Osteal Therapeutics

Osteal Therapeutics is a musculoskeletal therapeutics company developing solutions for the treatment of orthopedic infections. The company's lead product, VT-X7, is a drug-device combination that utilizes high concentrations of vancomycin and tobramycin, in conjunction with a drug delivery system, to irrigate infected joint spaces as a result of periprosthetic joint infection in joint replacement patients. 

Visit website.

David Thompson
David Thompson, CEO
Osteal Therapeutics

In-Person Presenter
OUI Medical

OUI Medical's micro-peritoneoscope is a disposable, portable handheld scope that includes an integrated camera, screen, processor, battery and biopsy forceps. The technology enables peritoneoscopy under local anesthesia at the point-of-care. 

Visit website.

Adarsh Patil
Adarsh Patil, Founder & Inventor
OUI Medical

In-Person Presenter
Oxford Endovascular

Having been spun-out from Oxford University, Oxford Endovascular is developing OxiFlow, a next-generation flow-diverter to reduce the risk of complications and ruptures in patients with intracranial aneurysms.

Visit website.

Mike Karim
Mike Karim, CEO
Oxford Endovascular

In-Person Presenter
Oxford Medical Products

Oxford Medical Products is developing a safe, effective, and affordable solution for weight loss. The Sirona solution consists of a self-expanding capsule that delivers a hydrogel into the stomach to create a sustained feeling of satiety. The hydrogel remains in the stomach for several days before degrading and being naturally digested. 

Visit website.

Camilla Easter
Camilla Easter, CEO
Oxford Medical Products

In-Person Presenter
PercuSense

PercuSense’s continuous multi-analyte sensor system combines monitoring of multiple biosensors with knowledge of how diseases and illness progress to intelligently and proactively recommend treatment.

Visit website.

Brian Kannard
Brian Kannard, Founder
PercuSense

In-Person Presenter
PhotoniCare

The OtoSight Middle Ear Scope enables clinicians to quickly and easily see directly through the eardrum to directly visualize the middle ear, drastically improving care for middle ear infections, the leading cause of hearing loss, antibiotic use, and surgeries in children. The novel device has new reimbursement codes that are seeing robust payment rates.

Visit website.

Cary Vance
Cary Vance, Chairman, President & CEO
PhotoniCare

In-Person Presenter
Pixium Vision

Bionic vision for those who have lost their sight. Bioelectronics and brain machine interface technology company specialized in neuromodulation application whose mission is to create a world of bionic vision for those who have lost their sight, enabling them to regain partial visual perception and greater autonomy.

Visit website.

Lloyd Diamond
Lloyd Diamond, CEO & Board Member
Pixium Vision

In-Person Presenter
Portal Instruments

Portal Instruments is developing a needle-free technology for the delivery of biologics. The handheld device is capable of delivering small and large molecules through subcutaneous, intradermal and intramuscular tissue layers. Portal's technology will improve the patient experience, providing greater comfort during drug administration.

Visit website.

Patrick Anquetil
Patrick Anquetil, CEO
Portal Instruments

In-Person Presenter
Positrigo

Positrigo is developing a functional positron emission tomography (PET) system with a small footprint at a fraction of the cost of current PET scanners. The company's NeuroLF system is an ultra-compact, dedicated PET system for applications in neurological (e.g., dementia, epilepsy) and neuro-oncology.

Visit website.

Jannis Fischer
Jannis Fischer, CEO
Positrigo

In-Person Presenter
Prana Thoracic

Prana Thoracic is developing an innovative approach to improve the early diagnosis of lung cancer. The company is developing the ThoraCore System, a CT-guided, catheter-based approach to perform a nodulectomy. The technology will be capable of safely coring, capturing suspicious pulmonary nodules, while sealing lung tissue using bipolar radiofrequency energy.

Visit website.

Joanna Nathan
Joanna Nathan, CEO
Prana Thoracic

In-Person Presenter
PredxBio

PredxBio is converging spatial analytics and artificial intelligence to transform precision pathology. The PredxBio Platform is an analytical software that is capable of predicting tumor initiation, progression, and response to therapy - enabling better outcomes for patients. With PredxBio, drug discovery and clinical development is enhanced with spatially intelligent biology.

Visit website.

Dusty Majumdar
Dusty Majumdar, CEO
PredxBio

In-Person Presenter booth icon Innovator Pavilion
Pretika

Pretika MedTech is reimagining outpatient and inpatient care with AI-powered Connected Wound Care technology.  The company's non-invasive, embedded medical device and wireless digital care cloud platform provides on demand or continuous imaging, sensor and data analytics for physicians and nursing teams to monitor post-surgery, wound and disease healing remotely or in-person without having to remove the surgical dressings, bandages, wraps or casts.

Visit website.

Thomas Nichols
Thomas Nichols, President
Pretika

In-Person Presenter booth icon Innovator Pavilion
Pristine Surgical

Pristine Surgical makes a high definition single-use visualization system for minimally invasive surgery and delivers its visualization devices in complete single-use kits. The devices utilize a low-cost image processing unit which also serves as a portal to cloud-based software supporting the entire surgical episode.

Visit website.

Bryan Lord
Bryan Lord, CEO
Pristine Surgical

In-Person Presenter
Promaxo

Next generation office-based modular MRI and MRI based technologies. Initial focus on advancing the solutions for prostate disease management and other urology and pelvic conditions.

Visit website.

Amit Vohra
Amit Vohra, President & CEO
Promaxo

In-Person Presenter
Purcell

Smart drug delivery solution for the management and treatment of respiratory diseases. 

Visit website.

Nicholas Purcell
Nicholas Purcell, Founder
Purcell

In-Person Presenter
Radiance Therapeutics

Next-generation beta ophthalmic applicator.

Visit website.

Laurence Marsteller
Laurence Marsteller, CEO
Radiance Therapeutics

In-Person Presenter
Rapid Nexus
Rapid Nexus has developed a first of its kind nanotechnology wound dressing, along  with devices that accelerate healing, to rapidly close chronic non-healing wounds. The wound management platform consists of a nanotechnology wound gel dressing formulation (HemastylRx) and Gen-Ray, a device to apply mild-heating to the wound to accelerate absorption and stimulate the healing process.

Visit website.

Dr. Margaret Kalmeta
Dr. Margaret Kalmeta, Founder & CEO
Rapid Nexus

In-Person Presenter booth icon Innovator Pavilion
RedDrop DX

RedDrop is a virtually pain-free, cost-effective, and easy-to-use whole blood and plasma collection system. The device, which can be used in home and healthcare settings, is capable of collecting high quality blood samples for diagnostic testing and remote clinical trials. 

Visit website.

Kris Buchanan
Kris Buchanan, CEO
RedDrop DX

In-Person Presenter booth icon Innovator Pavilion
Regain Laser Therapy

Regain Laser Therapy is a US-based medical device platform company with a strategic focus on regenerative medicine. The company is developing a proprietary, non-invasive, portable laser platform - the Regain Warrior. The tecnology is being designed to address limitations of the standard of care.

Visit website.

Joy Barton
Joy Barton, CEO
Regain Laser Therapy

In-Person Presenter
Relavo Medical

Relavo's mission is to improve the lives of people living with kidney failure. The company is changing the way people receiving peritoneal dialysis (PD) receive dialysis with its innovative in-line connection device - PeritoneX. Compatible with existing PD systems, PeritoneX internally disinfects dialysis tubes at all connection sites, preventing peritonitis and the costs associated with managing infections.

Visit website.

Sarah Lee
Sarah Lee, CEO
Relavo Medical

In-Person Presenter
SamanTree Medical

SamanTree Medical's Histolog Scanner is a digital microscopy scanner for high-resolution imaging of the surface of fresh tissue. The device utilizes novel, ultra-fast confocal microscopy technology to enable rapid histological assessment in the operating room or pathology laboratory. 

Visit website.

Olivier Delporte
Olivier Delporte, CEO
SamanTree Medical

In-Person Presenter
Samay

Samay uses a patented acoustic resonance technology to manage respiratory patients at-risk of exacerbations. Our first product, Sylvee, is a wearable sensor platform that continuously, passively and non-invasively monitors over 10+ lung function parameters in real time for 10x less than hospital-based testing

Visit website.

Maria Artunduaga
Maria Artunduaga, Founder & CEO
Samay

In-Person Presenter
Sana Health

Non-invasive bio-therapeutic device for pain management.

Visit website.

Richard Hanbury
Richard Hanbury, CEO
Sana Health

In-Person Presenter
Scalpel

Scalpel's digital platform has been designed to address key challenges and improve the operation of the operation room. Using artificial intelligence (AI) and noninvasive sensors, Scalpel helps hospitals and providers manage inventory, optimize instrument trays, and provide detailed peri-operative data analytics.

Visit website.

Yeshwanth Pulijala
Yeshwanth Pulijala, CEO
Scalpel

In-Person Presenter
Sentante

Sentante is developing a teleoperated/remote surgical robot for the performance of fully-robotic endovascular interventions. Artificial intelligence (AI) will enhance the capabilities of the system, enabling the performance of routine tasks during interventional cardiology procedures such as guidewire and catheter exchanges. 

Visit website.

Edvardas Satkauskas
Edvardas Satkauskas, CEO
Sentante

In-Person Presenter
SentiAR

Transforming the experience for both patient and clinician in interventional procedures with a 3D augmented reality platform featuring real-time holographic visualization of the patient’s actual anatomy, “floating” over the patient.

Visit website.

Berk Tas
Berk Tas, CEO
SentiAR

In-Person Presenter
Shoulder Innovations

Should Innovations' mission is to provide innovative solutions that address current challenges in shoulder arthroplasty. The company's flagship product, the InSet Glenoid Implant has been designed to address the most significant issue in shoulder arthroplasty - glenoid loosening. Since the introduction of the initial InSet Implant, the company has gone on to introduce additional products to continue to address unmet needs in shoulder repair.

Visit website.

Robert Ball
Robert Ball, CEO
Shoulder Innovations

In-Person Presenter
Smart Health Dx

SmartHealth Dx develops precision diagnostics that address unment needs in chronic diseases. The company is focused on how pathology tissue sample images are prepared, processed and viewed. SmartPath Dx is a rapid glass slide-free pathology instrument that produces high-quality digital images within minutes and allows sample tissue to remain intact. The company's technology is being implemented into multiple clinical applications, including cardiovascular disease, metabolic diseases, and oncology.

Visit website.

Mitch Levine
Mitch Levine, CEO
Smart Health Dx

In-Person Presenter
Smartlens

Smartlens has developed a device to enable "on the go" measurement of intraocular eye pressure. The company's flagship product, miLens, is an electronics-free device that provides seamless measurement capabilities to improve the early diagnosis of eye disease, certain neurological disorders, and cancers. In addition to the miLens product, the company's THERmic device applies micro-doses of personalized treatments for the treatment of glaucoma.

Visit website

Savas Komban
Savas Komban, CEO
Smartlens

In-Person Presenter
Solenic Medical

Solenic Medical is developing a non-invasive medical device that utilizes alternating magnetic fields to eradicate biofilms that form on implants. The company's platform uses external magnetic coils to destroy infective biofilms on the surface of knee and hi replacement implants, as well as plates and rods for trauma related procedures. Solenic's solution is being developed to replace the expensive and risky two-step revision surgery, which is the current standard of care for chronic infections on medical implants.

Visit website.

James Lancaster
James Lancaster, CEO
Solenic Medical

In-Person Presenter
Sonavex

Detecting flow compromise earlier using real-time, definitive, visual and quantitative blood flow monitoring — made possible with ultrasound.

Visit website.

David Narrow
David Narrow, CEO
Sonavex

In-Person Presenter
Sparta Biomedical

The first osseointegrative biomimetic knee cartilage implant.

Visit website.

Dushyanth Surakanti
Dushyanth Surakanti, CEO
Sparta Biomedical

In-Person Presenter
SpinaFX

SpinaFX Medical is committed to bridging the therapeutic gap (conservative vs. surgery) in the treatment of back and leg pain caused by a contained herniated disc. The company is pioneering a minimally invasive, image-guided treatment that injects a mixture of oxygen and ozone gas to reduce herniated disc volume. Clinical data shows that the solution leads to a reduction of disc volume, which relieves nerve root compression and herniated disc-related pain.

Visit website.

Jeff Cambra
Jeff Cambra, CEO
SpinaFX

In-Person Presenter
SpinePoint

SpinePoint is developing the next generation of interbody devices for spine surgery. The company's initial products include a low stiffness cervical cage and a pedicle screw for spinal fusion.

Visit website.

Lali Sekhon
Lali Sekhon, President
SpinePoint

In-Person Presenter
Stimdia Medical

Stimdia's pdSTIM system has been designed to electrically stimulate the phrenic nerves in a patient's neck to exercise the diaphragm during mechnical ventilation and minimize the impact of ventilation-induced diaphragmatic dysfunction. The temporary pacing stimulation is intended to support patients who have been ventilated for over 96 hours.

Visit website.

Tim Miller
Tim Miller, CEO
Stimdia Medical

In-Person Presenter
Stoparkinson

Stoparkinson's Earstim is a wearable electro-stimulation device intended to alleviate the symptoms of patients with Parkinson's disease without side effects.

Visit website.

Richard Lotti
Richard Lotti, President & CEO
Stoparkinson

booth icon Innovator Pavilion
SurePulse

SurePulse has identified a critical need for vital signs monitoring solutions for newborn babies. Current technologies have been adapted from devices for children and adults and are not suitable for newborn babies due to multiple factors. To address this limitation, the company has designed the SurePulse VS system, which uses a medical cap fitted with sensors to continuously monitor neonatal vital signs.

Visit website.

Dr. James Carpenter
Dr. James Carpenter, CEO
SurePulse

In-Person Presenter
Swiftsure

Switfsure Innovations is addressing the challenges in caring for ventilated patients in critical care. The company's first product is being developed to improve oral care and reduce the incidence of ventilator-acquired pneumonia and its associated complications due to poor oral care. 

Visit website.

Deanne McCarthy
Deanne McCarthy, CEO
Swiftsure

In-Person Presenter
TAE Life Sciences

TAE Life Sciences, a subsidiary of TAE Technologies, is leveraging accelerator-based neutron beam technology for Boron Neutron Capture Therapy (BNCT) to bring promising treatment potential for head and neck, glioblastoma multiforme (GBM) and other cancers that are difficult to treat with traditional methods. 

Visit website.

Rob Hill
Rob Hill, CEO
TAE Life Sciences

In-Person Presenter
Tally Surgical

Tally Surgical is developing a next generation solution to track and manage retained sponges in the operating room. Tally is designed to be a reliable, easy-to-use, and cost-effective retained sponge solution. The product provides OR staff with an accurate count of surgical sponges more efficiently than current solutions.

Visit website.

Brian Stewart
Brian Stewart, CEO
Tally Surgical

In-Person Presenter
The Patient Company

The Patient Company is reimagining the way that patients are moved with SimPull. As the first new patient movement platform in over 20 years, SimPull automates the movement of patients, beginning with lateral patient transfer, and is the first patient movement device that stores and shares data on patient movement. This data provides insights that inform patient movement activities while simultaneously reducing liability for caregivers and hospitals in a new, unique way.

Visit website.

Andrew Heuerman
Andrew Heuerman, CEO
The Patient Company

In-Person Presenter
The Shape Sensing Company

The Shape Sensing Company is seeking to take minimally invasive surgery into the next generation. Shape sensing technology utilizes fiber optic sensors to detect the shape and location of medical devices (e.g., catheters, endoscopes) within the body. The company's technology will minimize the complexity associated with traditional instrument navigating and tracking methods, such as fluoroscopy and ultrasound, while providing clinicians with comprehensive instrument tracking data.

Visit website.

Ryan DeBoer
Ryan DeBoer, Managing Director
The Shape Sensing Company

In-Person Presenter booth icon Innovator Pavilion
THINK Surgical

THINK Surgical develops and commercializes robotic surgery systems for the orthopedics market. The company's TSolution One is indicated for total knee arthroplasty. The system is capable of fully automated bone preparation that is personalized and prepared utilizing proprietary planning tools to achieve optimal fit of the selected knee implant.

Visit website.

Stuart Simpson
Stuart Simpson, CEO
THINK Surgical

In-Person Presenter
ThinkSono

ThinkSono is democratizing access to ultrasound devices. The company's ThinkSono AI platform uses artificial intelligence to guide and empower training with ultrasound at the point-of-care – allowing non-specialists to rapidly learn how to perform ultrasound examinations. Beyond ultrasound training, the company is developing AutoDVT, an AI-enabled solution that enables healthcare professionals to perform point-of-care scans for Deep Vein Thrombosis using a handheld ultrasound transducer and mobile phone.

Visit website.

Fouad Noor
Fouad Noor, Co-Founder & CEO
ThinkSono

In-Person Presenter
Total Flow Medical

Total Flow Medical is developing solutions to improve outcomes during patients undergoing heart surgery. The company's initial product is an easy-to-use cannula for use during minimally invasive cardiopulmonary bypass surgery. The device is being designed to improve the current clinical wokflow and patient quality of life.

Visit website.

Hillary Pierce
Hillary Pierce, CEO
Total Flow Medical

In-Person Presenter
TrackX Technology

TrackX Technologies is enhancing surgical instrument tracking with real-time, virtual live fluoroscopy. The company's Snap device provide visual guidance and real-time instrument tracking of the jamshidi needle during percutaneous pedicle screw placement procedures. 

Visit website.

Robert Isaacs
Robert Isaacs, CEO
TrackX Technology

In-Person Presenter
Trukera Medical

Trukera Medical is building a portfolio of products to address unmet needs in eye care for patients and providers. The company's ScoutPro osmolarity system is a handheld osmolarity testing device for the detection of toxic hyperosmolarity, a condition which damages corneal cells and drives refractive instability. 

Visit website.

Adam Szaronos
Adam Szaronos, CEO
Trukera Medical

In-Person Presenter
Vektor Medical

Vektor Medical's vMAP system helps identify the sources of stable and unstable arrhythmia using ECG data. Clinicians upload ECG data into the vMAP system, which then interprets and visualizes the data in 3D to identify sources of arrhythmia inside and outside of the heart. The vMAP system is capable of creating a "heat map" of the heart in minutes to support or improve ablation treatment planning.

Visite website.

Rob Krummen
Rob Krummen, CEO
Vektor Medical

In-Person Presenter
Vena Medical

Vena Medical is developing solutions to improve the way stroke is treated. The company's MicroAngioscope camera is capable of going inside the veins and arteries to visualize diseased lesions and help physicians treat stroke. The Vena BDAC system combines a balloon guide catheter with a distal access catheter to allow physicians to get closer to clots faster and more efficiently.

Visit website.

Michael Phillips
Michael Phillips, Co-Founder & CEO
Vena Medical

In-Person Presenter
Vena Vitals

Vena Vitals is an early stage med-tech company focused on non-invasive continuous blood pressure monitoring. The company's proprietary technology is a soft flexible sensor that conforms to the skin for direct pressure measurement at theradial artery. The company's technology is intended to replace unnecessarily invasive arterial line measurements as well as non-continuous cuff-based methods in both the hospital and at home.

Visit website.

Ray Liu
Ray Liu, CEO & Co-Founder
Vena Vitals

In-Person Presenter
Versono Medical

Versono is developing an intravascular ultrasonic platform to improve the crossing of severe occlusions in the peripheral vasculature. The device will prepare a working lumen to support endovascular therapy in patients with chronic total occlusions (CTOs) and critical limb ischemia (CLI).

Visit website.

Finbar Dolan
Finbar Dolan, CEO
Versono Medical

In-Person Presenter
Vessl Prosthetics

Vessl is providing a solution for the hundreds of thousands of amputees that struggle to adapt to loss of limb. The company is designing an automatically adjusting prosthetic socket which redistributes pressure around the leg in response to changes in limb size. The isoform prosthetic socket will improve quality-of-life for thousands of patients - allowing them to lead active and fulfilling lives.

Visit website.

Sydney Robinson
Sydney Robinson, CEO & Co-Founder
Vessl Prosthetics

In-Person Presenter
Vesteck

VESTECK Suture-Tight catheter secures endovascular aortic grafts to the aorta at the time of implant or during repair procedures.

Visit website.

Joseph Rafferty
Joseph Rafferty, CEO
Vesteck

In-Person Presenter
Veyond Metaverse

Veyond Metaverse is a healthtech company building a platform for medical education, remote surgical training and collaboration utilizing extended reality (XR) and artificial intelligence (AI). The platform is designed to be used in a variety of surgical specialties for both open and minimally invasive procedures.

Visite website.

Adam Choe
Adam Choe, CEO
Veyond Metaverse

In-Person Presenter booth icon Innovator Pavilion
VISIE

Formerly known as Advanced Scanners, VISIE is a 3D computer vision and spatial computing company researching, developing, and commercializing revolutionary optical scanners for robotic and navigated orthopedic, neuro, and spine surgery. VISIE’s proprietary imaging hardware and software combines the power of optical physics and deep tech to make the unseen seen in surgery. 

Visit website.

Douglas Fairbanks
Douglas Fairbanks, CEO
VISIE

In-Person Presenter
Visura Technologies

Visura manufacturers the world's first, FDA-cleared, disposable camera, the TEECAD System, that seamlessly connects to a transesophageal echocardiogram (TEE) echo probe, providing physicians real-time visualization for more efficient and effective probe placement for safer intubation.

Visit website.

Christine Horton
Christine Horton, CEO
Visura Technologies

In-Person Presenter
Vitestro

Vitestro, expert in medical robotics, was founded in 2017 to develop a device for autonomous blood collection in patients. The device combines ultrasound-guided 3D reconstruction based on AI with venipuncture. The procedure is fully automated, from tourniquet to applying a bandage. The premise for this innovation is to create a safe and consistent patient experience parallel to working towards a positive impact on solving the increasing shortage of healthcare personnel.

Visit website.

Toon Overbeeke
Toon Overbeeke, CEO
Vitestro

In-Person Presenter
Vomaris Innovations

Vomaris is harnessing the capacity of bioelectronics to develop solutions to support wound healing and reduce the risk of infection. V.Dox Technology generates electricity via a matrix of moisture-activated microcell batteries. The electric current mimics the skin's physiological electric energy to kill broad-spectrum pathogens found in conventional dressings. 

Visit website.

Michael Nagel
Michael Nagel, CEO
Vomaris Innovations

In-Person Presenter
Vonova

Vonova are improving access to care for patients afflicted with drug-resistant epilepsy. The Cerebro Atlas System uses the body's natural venous pathway to deliver an expandable neural interface that covers the region of the brain to identify seizure activity.

Visit website.

Wesley Jones
Wesley Jones, CEO
Vonova

In-Person Presenter
Watershed Therapeutics

Watershed Therapeutics is developing a platform that can more effectively treat acute and chronic urinary tract infections. 

Visit website.

Topher Kinsella
Topher Kinsella, CEO
Watershed Therapeutics

In-Person Presenter
Wearable Artificial Organs

Wearable Artificial Organs is developing truly portable solutions for use in patients with End Stage Renal Disease (ESRD). The company has currently prototyped two wearable device, a cordless continuous renal replacement therapy (CRRT) system and a wearable artificial kidney. 

Visit website.

Victor Gura
Victor Gura, CEO
Wearable Artificial Organs

In-Person Presenter
X-Bolt Trauma Orthopedics

X-Bolt develops next-generation devices for use during trauma surgeries. Key to the company's portfolio of orthopedic products are its expanding bolt design and the ability to easily reverse and remove implanted devices. 

Visit website.

Brian Thornes
Brian Thornes, CEO
X-Bolt Trauma Orthopedics

In-Person Presenter
Zeto

Zeto's electroencephalogram (EEG) is an FDA-cleared alternative to traditional EEG setups. The company has developed a wearable headset that is wireless, eliminates the need for preparation (e.g. gel application), and fully integrates with cloud data systems for real-time data viewing and management.

Visit website.

Aswin Gunasekar
Aswin Gunasekar, Founder & CEO
Zeto

In-Person Presenter
ZKR Orthopedics

New procedure to mimic the clinical effects of tibial osteotomy procedures. Implants will be delivered to the proximal tibia below the patellar tendon, offloading and re-directing the tendon to reduce pain and inflammation.

Visit website.

David Cash
David Cash, CEO
ZKR Orthopedics

In-Person Presenter
WHO IS ATTENDING

Companies We Work With